Moors & Cabot Inc. Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Moors & Cabot Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,229 shares of the healthcare conglomerate's stock after purchasing an additional 625 shares during the quarter. Moors & Cabot Inc.'s holdings in UnitedHealth Group were worth $4,163,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp grew its holdings in UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its holdings in UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after acquiring an additional 318,039 shares in the last quarter. Franklin Resources Inc. grew its holdings in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after acquiring an additional 193,800 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 0.5% during the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after acquiring an additional 36,394 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in UnitedHealth Group by 3.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate's stock worth $3,148,134,000 after acquiring an additional 182,361 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $486.54 on Wednesday. The firm's 50 day simple moving average is $512.82 and its 200-day simple moving average is $552.00. The company has a market cap of $445.04 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The firm's revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

Several analysts recently weighed in on UNH shares. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, KeyCorp restated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.